Kedrion Biopharma Strengthens Industry Connections at IgNS 2026 Conference #United_States #Las_Vegas #Kedrion_Biopharma #Immunoglobulin #IgNS_2026

Kedrion's QIVIGY® Receives Orphan Drug Designation for Rare Neurological Disorder #United_States #Fort_Lee,_NJ #Kedrion_Biopharma #QIVIGY #Stiff_Person_Syndrome